Hi Dan, here is some news about next weeks conference..Gordon
hursday October 29, 8:11 am Eastern Time
Company Press Release
Biopool International To Present Next Week at 21st
Annual Westergaard Waldorf Conference
Joins 16 Prospective High Growth Companies In Co-Hosting 250
Investment Professionals At All Day Institutional Meeting
NEW YORK--(BUSINESS WIRE)--Oct. 29, 1998-- Ventura, CA based Biopool
International (NASDAQ:BIPL - news) will be one of 16 prospective high growth microcap companies co- hosting the 21st
Annual Westergaard Microcap Conference next Thursday, November 5th, at the Waldorf Astoria in New York.
Biopool International manufactures a full range of test kits to assess and diagnose blood coagulation disorders, thrombotic risk
factors, fibrinolysis, platelet function and the vascular system, specialty chemistry controls used to monitor and measure the
presence of drugs of abuse, and blood group serology products used to screen for antibodies and group and type whole blood.
In welcoming Biopool to the November Conference, WBN Publisher John Westergaard commented.
''With the acquisition of the BCA division in January 1997, Biopool expanded its product offering to include blood group
serology reagents that are used to type and group donor and patient blood, as well as detect and identify various antigens and
antibodies in blood. The full Biopool product line addresses $1 billion of the $8-20 billion in vitro diagnostics worldwide
market.
''BIPL's product line of more than 150 FDA-approved products is sold to 4000 hospitals, blood bank facilities, and clinical
and reference laboratories in 70 countries by BIPL's sales representatives and by an extensive network of distributors. Sales in
the United States and Europe divided 63% and 23%, respectively, in 1997. No single customer exceeded 10%. Peer
companies are Digene Corporation (NASDAQ:DIGE - news); Enzo Biochem (AMEX:ENZ - news); Hemagen Diagnostics
(NASDAQ:HMGN - news); Immucor, Inc. (NASDAQ:BLUD - news); and Oxis International (NASDAQ:OXIS - news).''
Registration for CEO Michael Bick's presentation on November 5th is by invitation to investment professionals. Fax request for
details to 212-947-6643. |
